Main Line Health System:企業の戦略的SWOT分析

◆英語タイトル:Main Line Health System - Strategic SWOT Analysis Review
◆商品コード:DATA904C15785
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Main Line Health System – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Main Line Health System (MLHS) formerly, Jefferson Health System Inc, is a not for profit healthcare organization that provides healthcare services. It provides services through its core acute care hospitals, including Lankenau Medical Center, Paoli Hospital, Bryn Mawr Hospital, Riddle Hospital and Bryn Mawr Rehabilitation Hospital. It also includes Mirmont Treatment Center for drug and alcohol, Main Line Health Centers for lab and radiology, primary and specialty care and other outpatient services; HomeCare & Hospice for skilled home health care, hospice and home infusion services; Main Line HealthCare, a multispecialty physician networks; and Lankenau Institute for Medical Research, a biomedical research organization. MLHS care services include cancer, heart care, orthopedics, maternity care and women’s care, among others. MLHS is headquartered at Radnor, Pennsylvania, in US.

Main Line Health System Key Recent Developments

Sep 17,2018 LIMR investigator awarded NIH grant to study treatments for life-threatening cardiac arrhythmias
Aug 14,2018 Main Line Health hospitals ranked among the top hospitals in the region by U.S. News & World Report
Jul 05,2018 Revving Up Innate Control of Viral Infection Requires a Three-Cell Ignition
Jul 02,2018 Main Line Health holds ribbon cutting to mark opening of LGBTQ Inclusive Care
Jun 12,2018 Main Line Health breaks ground on health center in King of Prussia

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Main Line Health System – Key Facts
Main Line Health System – Key Employees
Main Line Health System – Key Employee Biographies
Main Line Health System – Major Products and Services
Main Line Health System – History
Main Line Health System – Company Statement
Main Line Health System – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Main Line Health System – Business Description
Main Line Health System – SWOT Analysis
SWOT Analysis – Overview
Main Line Health System – Strengths
Main Line Health System – Weaknesses
Main Line Health System – Opportunities
Main Line Health System – Threats
Main Line Health System – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Main Line Health System, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Main Line Health System, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Main Line Health System, Recent Deals Summary
Section 4 – Company’s Recent Developments
Sep 17, 2018: LIMR investigator awarded NIH grant to study treatments for life-threatening cardiac arrhythmias
Aug 14, 2018: Main Line Health hospitals ranked among the top hospitals in the region by U.S. News & World Report
Jul 05, 2018: Revving Up Innate Control of Viral Infection Requires a Three-Cell Ignition
Jul 02, 2018: Main Line Health holds ribbon cutting to mark opening of LGBTQ Inclusive Care
Jun 12, 2018: Main Line Health breaks ground on health center in King of Prussia
Apr 16, 2018: Six Health Systems form Consortium to Expand Access to Clinical Trials, Bringing Access to Clinical Trials Closer to Home
Feb 09, 2018: Main Line Health announces plan to build health center in King of Prussia
Jan 16, 2018: Lankenau Institute for Medical Research investigators develop novel therapy for melanoma tumors
Jan 02, 2018: Main Line Health hospitals are top performers in new CMS overall quality star ratings
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Main Line Health System, Key Facts
Main Line Health System, Key Employees
Main Line Health System, Key Employee Biographies
Main Line Health System, Major Products and Services
Main Line Health System, History
Main Line Health System, Other Locations
Main Line Health System, Subsidiaries
Main Line Health System, Key Competitors
Main Line Health System, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Main Line Health System, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Main Line Health System, Recent Deals Summary

List of Figures
Main Line Health System, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Main Line Health System, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Main Line Health System:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ARRIS International PLC:企業の戦略的SWOT分析
    ARRIS International PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Grupo Aeroportuario del Pacifico SAB de CV:企業の戦略・SWOT・財務情報
    Grupo Aeroportuario del Pacifico SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Aeroportuario del Pacifico SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Whirlpool Corporation:企業の戦略・SWOT・財務情報
    Whirlpool Corporation - Strategy, SWOT and Corporate Finance Report Summary Whirlpool Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Silgan Holdings Inc.:企業の戦略・SWOT・財務情報
    Silgan Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Silgan Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Harry Ramsden’s:企業の戦略・SWOT・財務分析
    Harry Ramsden's - Strategy, SWOT and Corporate Finance Report Summary Harry Ramsden's - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Flight Centre Travel Group Limited (FLT):企業の財務・戦略的SWOT分析
    Flight Centre Travel Group Limited (FLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Sul America SA:企業の戦略・SWOT・財務情報
    Sul America SA - Strategy, SWOT and Corporate Finance Report Summary Sul America SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Daimler AG (DAI):企業の財務・戦略的SWOT分析
    Daimler AG (DAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The Norwegian Radium Hospital Research Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary The Norwegian Radium Hospital Research Foundation (Radium Hospital) is a research center that conducts research programs and clinical studies. The center invests in oncology, novel therapeutics and diagnostics. It operates as a hub for cancer and oncology treatment research. Radium Hospital …
  • Lombard Odier Private Clients:企業の戦略・SWOT・財務情報
    Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report Summary Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Globeimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Globeimmune Inc (Globeimmune) is a biopharmaceutical company that develops therapeutic products for treatment of cancer and infectious diseases. The company provides products for infectious disease and oncology. It offers oncology products such as GI-4000, GI-6207 and GI-6301. Globeimmune pr …
  • Intuitive Surgical Inc (ISRG)-医療機器分野:企業M&A・提携分析
    Summary Intuitive Surgical Inc (Intuitive Surgical) is a provider of robotic-assisted minimally invasive surgery (MIS) devices. Its portfolio encompasses da Vinci Surgical Systems, InSite and Firefly Fluorescence imaging systems (Firefly), instruments and accessories and training technologies. The c …
  • Waterman Group Plc (WTM):企業の財務・戦略的SWOT分析
    Summary Waterman Group Plc (Waterman), formerly Waterman Partnership Holdings Plc, a subsidiary of CTI Engineering Co Ltd, is an engineering and environmental consultancy service provider that offers services for property, infrastructure, environment and energy markets. The company provides services …
  • Aqua Bio Technology ASA (ABT):企業の財務・戦略的SWOT分析
    Summary Aqua Bio Technology ASA (ABT) is a biotechnology company that develops, produces and markets new active ingredients. The company’s products comprise Aquabeautine XL and Smids. Its product Aquabeautine XL is derived from the hatching fluid of salmon. ABT’s products are based on research and d …
  • Georgia Power Co (GPW):電力:M&Aディール及び事業提携情報
    Summary Georgia Power Co (Georgia Power), a subsidiary of the Southern Power Company, generates, transmits, distributes and sells electricity. The company produces electricity using various sources of energy such as coal, nuclear, solar, gas and hydro. It supplies electricity in Georgia and to whole …
  • F J Benjamin Holdings Ltd.:企業の戦略・SWOT・財務情報
    F J Benjamin Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary F J Benjamin Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Factor Therapeutics Ltd (FTT):企業の財務・戦略的SWOT分析
    Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd, is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor …
  • Freehold Royalties Ltd (FRU):石油・ガス:M&Aディール及び事業提携情報
    Summary Freehold Royalties Ltd (Freehold Royalties), formerly Freehold Royalty Trust is an oil and gas company that offers oil and gas operation and financial performance. The company's oil and gas assets generate income from natural gas, crude oil, natural gas liquids and potash deposits. It provid …
  • Oil & Gas Development Co Ltd (OGDC):企業の財務・戦略的SWOT分析
    Oil & Gas Development Co Ltd (OGDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Unum Therapeutics Inc (UMRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Unum Therapeutics Inc (Unum Therapeutics) is a clinical-stage bio-pharmaceutical company focused on the development and commercialization of novel antibody-coupled cellular immunotherapies to fight cancers. Its pipeline product portfolio include ACTR087 + rituximab, a CD20 targeting chimeric …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆